F. Vences-Catalán, C. Duault, C. C. Kuo, R. Rajapaksa, R. Levy, S. Levy: CD81 as a tumor target. In: Biochemical Society transactions. Band 45, Nummer 2, April 2017, S.531–535, doi:10.1042/BST20160478, PMID 28408492.
Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME:NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. In: J. Biol. Chem. 272. Jahrgang, Nr.46, November 1997, S.29181–9, doi:10.1074/jbc.272.46.29181, PMID 9360996 (englisch).
Horváth G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E:CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. In: J. Biol. Chem. 273. Jahrgang, Nr.46, November 1998, S.30537–43, doi:10.1074/jbc.273.46.30537, PMID 9804823 (englisch).
Radford KJ, Thorne RF, Hersey P:CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. In: Biochem. Biophys. Res. Commun. 222. Jahrgang, Nr.1, Mai 1996, S.13–8, doi:10.1006/bbrc.1996.0690, PMID 8630057 (englisch).
Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E:The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. In: J. Biol. Chem. 276. Jahrgang, Nr.17, April 2001, S.14329–37, doi:10.1074/jbc.M011297200, PMID 11278880 (englisch).
Stipp CS, Orlicky D, Hemler ME:FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein. In: J. Biol. Chem. 276. Jahrgang, Nr.7, Februar 2001, S.4853–62, doi:10.1074/jbc.M009859200, PMID 11087758 (englisch).
Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, Boucheix C, Rubinstein E:Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. In: Biochem. J. 340. Jahrgang, Pt 1, Mai 1999, S.103–11, doi:10.1042/0264-6021:3400103, PMID 10229664, PMC1220227(freier Volltext) – (englisch).
Levy S, Todd SC, Maecker HT:CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. In: Annu Rev Immunol. 16. Jahrgang, 1998, S.89–109, doi:10.1146/annurev.immunol.16.1.89, PMID 9597125 (englisch).
B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, F. L. Cosset: Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. In: The Journal of biological chemistry. Band 278, Nummer 43, Oktober 2003, S.41624–41630, doi:10.1074/jbc.M305289200, PMID 12913001.
S. Yalaoui, S. Zougbédé, S. Charrin, O. Silvie, C. Arduise, K. Farhati, C. Boucheix, D. Mazier, E. Rubinstein, P. Froissard: Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. In: PLoS pathogens. Band 4, Nummer 2, Februar 2008, S.e1000010, doi:10.1371/journal.ppat.1000010, PMID 18389082, PMC2279262(freier Volltext).
O. Silvie, E. Rubinstein, J. F. Franetich, M. Prenant, E. Belnoue, L. Rénia, L. Hannoun, W. Eling, S. Levy, C. Boucheix, D. Mazier: Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. In: Nature medicine. Band 9, Nummer 1, Januar 2003, S.93–96, doi:10.1038/nm808, PMID 12483205.
L. A. Fast, D. Lieber, T. Lang, L. Florin: Tetraspanins in infections by human cytomegalo- and papillomaviruses. In: Biochemical Society transactions. Band 45, Nummer 2, April 2017, S.489–497, doi:10.1042/BST20160295, PMID 28408489.
Rajesh S, Sridhar P, Tews BA, Fénéant L, Cocquerel L, Ward DG, Berditchevski F, Overduin M:Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81. In: J Virol. 86. Jahrgang, Nr.18, Juni 2012, S.9606–16, doi:10.1128/JVI.00559-12, PMID 22740401, PMC3446547(freier Volltext) – (englisch).
Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW:Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization. In: Molecules. 13. Jahrgang, Nr.5, 2008, S.1081–110, doi:10.3390/molecules13051081, PMID 18560330 (englisch).
F. Vences-Catalán, C. Duault, C. C. Kuo, R. Rajapaksa, R. Levy, S. Levy: CD81 as a tumor target. In: Biochemical Society transactions. Band 45, Nummer 2, April 2017, S.531–535, doi:10.1042/BST20160478, PMID 28408492.
Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Hemler ME:NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. In: J. Biol. Chem. 272. Jahrgang, Nr.46, November 1997, S.29181–9, doi:10.1074/jbc.272.46.29181, PMID 9360996 (englisch).
Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF:The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. In: J. Immunol. 149. Jahrgang, Nr.9, November 1992, S.2841–50, PMID 1383329 (englisch).
Imai T, Kakizaki M, Nishimura M, Yoshie O:Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. In: J. Immunol. 155. Jahrgang, Nr.3, August 1995, S.1229–39, PMID 7636191 (englisch).
Horváth G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E:CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. In: J. Biol. Chem. 273. Jahrgang, Nr.46, November 1998, S.30537–43, doi:10.1074/jbc.273.46.30537, PMID 9804823 (englisch).
Radford KJ, Thorne RF, Hersey P:CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. In: Biochem. Biophys. Res. Commun. 222. Jahrgang, Nr.1, Mai 1996, S.13–8, doi:10.1006/bbrc.1996.0690, PMID 8630057 (englisch).
Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E:The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. In: J. Biol. Chem. 276. Jahrgang, Nr.17, April 2001, S.14329–37, doi:10.1074/jbc.M011297200, PMID 11278880 (englisch).
Stipp CS, Orlicky D, Hemler ME:FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein. In: J. Biol. Chem. 276. Jahrgang, Nr.7, Februar 2001, S.4853–62, doi:10.1074/jbc.M009859200, PMID 11087758 (englisch).
N. Anzai, Y. Lee, B. S. Youn, S. Fukuda, Y. J. Kim, C. Mantel, M. Akashi, H. E. Broxmeyer: C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors. In: Blood. Band 99, Nummer 12, Juni 2002, S.4413–4421, PMID 12036870.
Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, Boucheix C, Rubinstein E:Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. In: Biochem. J. 340. Jahrgang, Pt 1, Mai 1999, S.103–11, doi:10.1042/0264-6021:3400103, PMID 10229664, PMC1220227(freier Volltext) – (englisch).
A. Mazzocca, V. Carloni, S. Sciammetta, C. Cordella, P. Pantaleo, A. Caldini, P. Gentilini, M. Pinzani: Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. In: Journal of hepatology. Band 37, Nummer 3, September 2002, S.322–330, PMID 12175627.
K. L. Clark, Z. Zeng, A. L. Langford, S. M. Bowen, S. C. Todd: PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. In: Journal of Immunology. Band 167, Nummer 9, November 2001, S.5115–5121, PMID 11673522.
Levy S, Todd SC, Maecker HT:CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. In: Annu Rev Immunol. 16. Jahrgang, 1998, S.89–109, doi:10.1146/annurev.immunol.16.1.89, PMID 9597125 (englisch).
B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, F. L. Cosset: Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. In: The Journal of biological chemistry. Band 278, Nummer 43, Oktober 2003, S.41624–41630, doi:10.1074/jbc.M305289200, PMID 12913001.
S. Yalaoui, S. Zougbédé, S. Charrin, O. Silvie, C. Arduise, K. Farhati, C. Boucheix, D. Mazier, E. Rubinstein, P. Froissard: Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. In: PLoS pathogens. Band 4, Nummer 2, Februar 2008, S.e1000010, doi:10.1371/journal.ppat.1000010, PMID 18389082, PMC2279262(freier Volltext).
O. Silvie, E. Rubinstein, J. F. Franetich, M. Prenant, E. Belnoue, L. Rénia, L. Hannoun, W. Eling, S. Levy, C. Boucheix, D. Mazier: Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. In: Nature medicine. Band 9, Nummer 1, Januar 2003, S.93–96, doi:10.1038/nm808, PMID 12483205.
L. A. Fast, D. Lieber, T. Lang, L. Florin: Tetraspanins in infections by human cytomegalo- and papillomaviruses. In: Biochemical Society transactions. Band 45, Nummer 2, April 2017, S.489–497, doi:10.1042/BST20160295, PMID 28408489.
Rajesh S, Sridhar P, Tews BA, Fénéant L, Cocquerel L, Ward DG, Berditchevski F, Overduin M:Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81. In: J Virol. 86. Jahrgang, Nr.18, Juni 2012, S.9606–16, doi:10.1128/JVI.00559-12, PMID 22740401, PMC3446547(freier Volltext) – (englisch).
Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW:Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization. In: Molecules. 13. Jahrgang, Nr.5, 2008, S.1081–110, doi:10.3390/molecules13051081, PMID 18560330 (englisch).
